Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.

[1]  R. Abrams.  Cholangiocarcinoma--what level of evidence should we have? , 2009, International journal of radiation oncology, biology, physics.

[2]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[3]  G. Gustafson,et al.  Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. , 2007, International journal of radiation oncology, biology, physics.

[4]  M. Hoogeman,et al.  Update of the Results of the Dutch Multicenter Dose Escalation Trial of Radiotherapy for Localized Prostate Cancer , 2007 .

[5]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[6]  Joos V Lebesque,et al.  Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. , 2006, International journal of radiation oncology, biology, physics.

[7]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[8]  P. Koper,et al.  Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[9]  M. Hoogeman,et al.  Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[10]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[11]  M. Hoogeman,et al.  Absolute and relative dose–surface and dose–volume histograms of the bladder: which one is the most representative for the actual treatment? , 2005, Physics in medicine and biology.

[12]  M. V. van Herk,et al.  The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[14]  R. Eeles,et al.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects , 2005, British Journal of Cancer.

[15]  P. Levendag,et al.  Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Andrew Jackson,et al.  High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated. , 2004, International journal of radiation oncology, biology, physics.

[17]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[18]  Joos V Lebesque,et al.  Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. , 2002, International journal of radiation oncology, biology, physics.

[19]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[20]  A. Markoe,et al.  Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.

[21]  J. Denham,et al.  Is there more than one late radiation proctitis syndrome? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  D. Dearnaley,et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.

[23]  A Bel,et al.  High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. , 1996, International journal of radiation oncology, biology, physics.

[24]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.